RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
ZAGONEL V
Collezione ASL Biella
Items : 16
Pertuzumab and trastuzumab emtansine in patients with HER2-amplified metastatic colorectal cancer: the phase II HERACLES-B trial. in ESMO open / ESMO Open. 2020 Sep;5(5):e000911. doi: 10.1136/esmoopen-2020-000911.
2020
ASL Biella
Siena S; Marsoni S; Trusolino L; Bardelli A; Sapino A; Vanzulli A; Regge D; Cappello G; Bonoldi E; Torri V; Bencardino K; Valtorta E; Ardizzoni A; Grassi E; Amatu A; Ciardiello F; Zagonel V; Bergamo F; Martino C; Fenocchio E; Tosi F; Leone F; Ghezzi S; Lonardi S; Sartore-Bianchi A;
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy. in Cancers / Cancers (Basel). 2020 May 22;12(5):1330. doi: 10.3390/cancers12051330.
2020
ASL Biella
Scartozzi M; Labianca R; Cascinu S; Puzzoni M; Libertini M; Zagonel V; Codecà C; Germano D; Lai E; Sozzi P; Pusceddu V; Zampino MG; Demurtas L; Pella N; Casagrande M; Cavanna L; Rosati G; Zaniboni A; Ferrari D; Lonardi S; Zizzi A; Daniele B; Ziranu P; Giampieri R;
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. in The oncologist / Oncologist. 2020 Jun;25(6):481-487. doi: 10.1634/theoncologist.2019-0611. Epub 2020 Jan 22.
2020
ASL Biella
Fassan M; Zagonel V; Lonardi S; Nguyen A; Schirripa M; Sanborn JZ; Dei Tos AP; Golovato J; Rugge M; Salmaso R; Munari G; Zapata L; Sottoriva A; Valeri N; Bonetti LR; Maddalena G; Cascinu S; Spallanzani A; Leone F; Lombardi P; Filippi R; Prete AA; Biason P; Intini R; Depetris I; Loupakis F;
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. in Scientific reports / Sci Rep. 2020 Jan 31;10(1):1918. doi: 10.1038/s41598-020-58486-6.
2020
ASL Biella
Magnani M; Frontini L; Sobrero A; Bergamo F; Lazzarelli S; Verusio C; Turci D; Biondi E; Bramati A; Foltran L; Nicolini M; Ricci V; Barni S; Veltri E; Sozzi P; Ionta MT; Bagaloni I; Zagonel V; Pella N; Mucciarini C; Massidda B; Labianca R; Lonardi S; Ronzoni M; Graziano F; Galli F; Galli F; Ruzzo A; Rulli E; et alii...
Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer. in Clinical colorectal cancer / Clin Colorectal Cancer. 2020 Dec;19(4):256-262.e2. doi: 10.1016/j.clcc.2020.06.009. Epub 2020 Jun 27
2020
ASL Biella
Leone F; Ghezzi S; Martino C; Bencardino K; Bonazzina E; Bergamo F; Fenocchio E; Martinelli E; Troiani T; Siravegna G; Mauri G; Marsoni S; Siena S; Trusolino L; Bardelli A; Zagonel V; Regge D; Ciardiello F; Bonoldi E; Vanzulli A; Marrapese G; Valtorta E; Tosi F; Cappello G; Cassingena A; Torri V; Amatu A; Lonardi S; Sartore-Bianchi A; et alii...
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. in Scientific reports / Sci Rep. 2019 Aug 8;9(1):11527. doi: 10.1038/s41598-019-47627-1.
2019
ASL Biella
Magnani M; Frontini L; Sobrero A; Bergamo F; Lazzarelli S; Verusio C; Turci D; Biondi E; Bramati A; Foltran L; Nicolini M; Ricci V; Barni S; Veltri E; Sozzi P; Ionta MT; Bagaloni I; Zagonel V; Pella N; Mucciarini C; Massidda B; Labianca R; Lonardi S; Ronzoni M; Graziano F; Galli F; Galli F; Ruzzo A; Rulli E; et alii...
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Sep;83:106-115. doi: 10.1016/j.ejca.2017.06.029. Epub 2017 Jul 20.
2017
ASL Biella
Galli F; Ronzoni M; Scartozzi M; Labianca R; Ferraú F; Giordano M; Corsi DC; Zagonel V; Bilancia D; Iaffaioli RV; Leone F; Zaniboni A; Marchetti P; Lonardi S; Rosati G; Nasti G; Cascinu S;
Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. in British journal of cancer / Br J Cancer. 2017 Oct 24;117(9):1269-1277. doi: 10.1038/bjc.2017.289. Epub 2017 Aug 24.
2017
ASL Biella
Magnani M; Frontini L; Sobrero A; Verusio C; Bergamo F; Bramati A; Lazzarelli S; Turci D; Biondi E; Foltran L; Nicolini M; Ricci V; Barni S; Bagaloni I; Veltri E; Sozzi P; Ionta MT; Labianca R; Zagonel V; Pella N; Mucciarini C; Rulli E; Galli F; Massidda B; Ronzoni M; Lonardi S; Ruzzo A; Galli F; Graziano F; et alii...
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial. in British journal of cancer / Br J Cancer. 2017 Oct 10;117(8):1099-1104. doi: 10.1038/bjc.2017.234. Epub 2017 Sep 19.
2017
ASL Biella
Cascinu S; Labianca R; Codecà C; Libertini M; Zagonel V; Sozzi P; Germano D; Zampino MG; Pella N; Rosati G; Cavanna L; Zaniboni A; Lonardi S; Ferrari D; Daniele B; Puzzoni M; Giampieri R; Scartozzi M;
Erratum to "Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life" [Eur J Cancer 69 (2016) 110-118]. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2017 Feb;72:272-273. doi: 10.1016/j.ejca.2016.11.024. Epub 2016 Dec 24.
2017
ASL Biella
AOU Città della Salute di Torino
ASL Alessandria
Casadei Gardini A; Monti M; Nanni O; Pedrazzoli P; Frassineti GL; Galiano A; Alquati S; Quadrini S; Zagonel V; Cavanna L; Ferrari D; Giacobino A; Luzzani M; Luchena G; Fioretto L; Cattaneo MT; Bortolussi R; Garetto F; Biasini C; Codecà C; Broglia CM; Sansoni E; Scarpi E; Schiavon S; Dall'Agata M; Maltoni M;
2017
ASL Biella
AO Ordine Mauriziano
Ruzzo A; Galli F; Rulli E; Lonardi S; Zagonel V; Ronzoni M; Ionta MT; Pella N; Mucciarini C; Labianca R; Veltri E; Sozzi P; Barni S; Nicolini M; Biondi E; Bramati A; Turci D; Buscaglia M; Magnani M; Graziano F; Tampellini M; Falco E; De Rosa G; Montarolo F; Dacomo R; Baratelli C; Sperti E; Di Maio M; Scagliotti GV; et alii...
Germline variants and clinical outcomes of high-risk stage II and stage III colon cancer patients treated with oxaliplatin and fluoropyrimidines adjuvant chemotherapy: a pharmacogenetic ancillary study to TOSCA trial in Annals of oncology : official journal of the European Society for Medical Oncology
2017
ASL Biella
Ruzzo A; Galli F; Rulli E; Lonardi S; Zagonel V; Ronzoni M; Ionta MT; Pella N; Mucciarini C; Labianca R; Veltri E; Sozzi P; Barni S; Nicolini M; Biondi E; Bramati A; Turci D; Buscaglia M; Magnani M; Graziano F;
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2016 Sep;65:61-8. doi: 10.1016/j.ejca.2016.06.007. Epub 2016 Jul 26.
2016
ASL Biella
AOU Città della Salute di Torino
ASL Alessandria
Maltoni M; Amadori D; Nanni O; Casadei Gardini A; Pini S; Farolfi A; Valgiusti M; Trentin L; Broglia CM; Bortolussi R; Ferrari D; Dall'Agata M; Zagonel V; Bertè R; Scarpi E;
Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2016 Dec;69:110-118. doi: 10.1016/j.ejca.2016.10.004. Epub 2016 Nov 4.
2016
ASL Biella
AOU Città della Salute di Torino
Monti M; Nanni O; Casadei Gardini A; Pedrazzoli P; Frassineti GL; Galiano A; Ferrari D; Cavanna L; Zagonel V; Quadrini S; Luchena G; Alquati S; Luzzani M; Cattaneo MT; Giacobino A; Fioretto L; Bortolussi R; Garetto F; Sansoni E; Broglia CM; Codecà C; Biasini C; Schiavon S; Scarpi E; Dall'Agata M; Maltoni M;
2016
ASL Biella
Scartozzi M; Giampieri R; Daniele B; Ferrari D; Lonardi S; Zaniboni A; Cavanna L; Rosati G; Pella N; Zampino MG; Sozzi P; Casula L; Cozzi L; Germano D; Puzzoni M; Loretelli C; Zagonel V; Labianca R; Frontini L; Cascinu S;
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. in Scientific reports / Sci Rep. 2014 Nov 5;4:6828. doi: 10.1038/srep06828.
2014
ASL Biella
Magnani M; Verusio C; Frontini L; Sobrero A; Bergamo F; Turci D; Lazzarelli S; Bramati A; Foltran L; Biondi E; Nicolini M; Mucciarini C; Labianca R; Ionta MT; Veltri E; Sozzi P; Barni S; Ricci V; Pella N; Lonardi S; Ronzoni M; Massidda B; Zagonel V; Galli F; Floriani I; Rulli E; Graziano F; Galli F; Giacomini E; et alii...